Page last updated: 2024-11-05

2,4-thiazolidinedione and Lung Neoplasms

2,4-thiazolidinedione has been researched along with Lung Neoplasms in 7 studies

thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.

Lung Neoplasms: Tumors or cancer of the LUNG.

Research Excerpts

ExcerptRelevanceReference
"Metformin is a widely used antidiabetic drug, which also displays significant growth inhibitory and proapoptotic effects in several cancer models, including lung cancer, alone or in combination with chemotherapeutic drugs."2.49Metformin in lung cancer: rationale for a combination therapy. ( Capuano, A; Ciardiello, F; Della Corte, CM; Festino, L; Manzo, A; Martinelli, E; Morgillo, F; Sasso, FC; Troiani, T, 2013)
"Lung cancer is caused by combinations of diverse genetic mutations."1.42Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis. ( Cha, JH; Choi, JW; Jeong, Y; Kim, HW; Kim, J; Larsen, JE; Minna, JD; Sato, M; Yeh, BI, 2015)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's4 (57.14)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Hua, TNM1
Namkung, J1
Phan, ANH1
Vo, VTA1
Kim, MK1
Jeong, Y2
Choi, JW2
Morgillo, F1
Sasso, FC1
Della Corte, CM1
Festino, L1
Manzo, A1
Martinelli, E1
Troiani, T1
Capuano, A1
Ciardiello, F1
Kim, J1
Sato, M2
Kim, HW1
Yeh, BI1
Larsen, JE1
Minna, JD1
Cha, JH1
Momoi, A1
Murao, K1
Imachi, H1
Ishida, T1
Cao, WM1
Takahara, J1
Satoh, T1
Toyoda, M1
Hoshino, H1
Monden, T1
Yamada, M2
Shimizu, H1
Miyamoto, K1
Mori, M2
Hanafy, NS1
Aziz, NAAM1
El-Hddad, SSA1
Abdelgawad, MA1
Ghoneim, MM1
Dawood, AF1
Mohamady, S1
El-Adl, K1
Ahmed, S1
Rodrigues, MDD1
Santiago, PBGS1
Marques, KMR1
Pereira, VRA1
de Castro, MCAB1
Cantalice, JCLL1
da Silva, TG1
Adam, ML1
do Nascimento, SC1
de Albuquerque, JFC1
Militao, GCG1

Reviews

1 review available for 2,4-thiazolidinedione and Lung Neoplasms

ArticleYear
Metformin in lung cancer: rationale for a combination therapy.
    Expert opinion on investigational drugs, 2013, Volume: 22, Issue:11

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small

2013

Other Studies

6 other studies available for 2,4-thiazolidinedione and Lung Neoplasms

ArticleYear
PPARgamma-mediated ALDH1A3 suppression exerts anti-proliferative effects in lung cancer by inducing lipid peroxidation.
    Journal of receptor and signal transduction research, 2018, Volume: 38, Issue:3

    Topics: Aldehyde Oxidoreductases; Aldehydes; Apoptosis; Binding Sites; Cell Line, Tumor; Cell Proliferation;

2018
Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis.
    PloS one, 2015, Volume: 10, Issue:8

    Topics: Bronchi; Cell Line, Transformed; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic;

2015
Inhibition of monocyte chemoattractant protein-1 expression in cytokine-treated human lung epithelial cells by thiazolidinedione.
    Chest, 2001, Volume: 120, Issue:4

    Topics: Adenocarcinoma; Chemokine CCL2; Gene Expression; Humans; Interleukin-1; Lung; Lung Neoplasms; Respir

2001
Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells.
    Oncogene, 2002, Mar-28, Volume: 21, Issue:14

    Topics: Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; CCAAT-Enhancer-Binding Proteins; Cell

2002
Design, synthesis, and docking of novel thiazolidine-2,4-dione multitarget scaffold as new approach for cancer treatment.
    Archiv der Pharmazie, 2023, Volume: 356, Issue:7

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; ErbB

2023
Selective cytotoxic and genotoxic activities of 5-(2-bromo-5-methoxybenzylidene)-thiazolidine-2,4-dione against NCI-H292 human lung carcinoma cells.
    Pharmacological reports : PR, 2018, Volume: 70, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Comet Assay; Cytotoxins; DNA Fragmentation; HL-6

2018